As both kind of diabetes continues to be prevalent among the world’s population, the same goes for experts when it comes to developing ways to manage the disease or maybe even cure it for good. Recently, it was reported that an Ayurvedic supplement can help reduce the blood sugar levels in a person who suffers from type 2 diabetes.
Like with any disease or condition, there are people who prefer taking a more natural approach to treat it or manage it better compared to using prescription medication. Express reports that this certain Ayurvedic supplement was proven to be able to lower the blood sugar levels in a person, which could be beneficial for those suffering from type 2 diabetes. To be specific, the Gymnema supplements.
Gymnema is short for Gymnema Sylvestre, which is a herb that is used in treating or managing diabetes through an Ayurvedic means. Ayurvedic refers to the type of treatment that stems from India. This herb is referred to as “gumar,” in Hindu, which translates to “sugar destroyer,” an appropriate name for its purpose.
This was proven in a study, where patients who suffer from type 2 diabetes took 400mg of Gymnema leaf extract every day for a period of 18 to 20 months. Within the time frame, it was revealed that the participants’ blood sugar levels have lowered by up to 29 percent.
Further research could also prove that this supplement can also be beneficial for those with type 1 diabetes. This is because it helps suppress cravings for sweets through the sweet-taste sensation in the mouth. According to experts, Gymnema works by reducing the gut’s ability to absorb sugar, and therefore promote the uptake of sugar from the blood at a cellular level. For type 1 diabetes, it can also help in the production of insulin from the pancreas.
This type of treatment is becoming more and more popular in the West, as many people have begun to resort to this method when it comes to managing or curing their conditions. When it comes to type 2 diabetes, in order for this method to work, major changes in lifestyle such as diet and exercise should be done as well, to lower blood sugar levels.


Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



